{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:47:00Z","timestamp":1791362820864,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00277-019-03715-w","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:52:05Z","timestamp":1559127125000},"page":"1877-1883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100\u00a0days after allogeneic stem cell transplantation"],"prefix":"10.1007","volume":"98","author":[{"given":"Yu-Qian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"issue":"10","key":"3715_CR1","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00277-015-2440-x","volume":"94","author":"YQ Sun","year":"2015","unstructured":"Sun YQ, He GL, Chang YJ, Xu LP, Zhang XH, Han W, Chen H, Chen YH, Wang Y, Wang FR, Wang JZ, Liu KY, Huang XJ (2015) The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation. Ann Hematol 94(10):1699\u20131705. \n                    https:\/\/doi.org\/10.1007\/s00277-015-2440-x","journal-title":"Ann Hematol"},{"issue":"8","key":"3715_CR2","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringden OT, Pasquini MC, Schriber JR, Cooke KR (2015) Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia 29(8):1754\u20131762. \n                    https:\/\/doi.org\/10.1038\/leu.2015.75","journal-title":"Leukemia"},{"issue":"25","key":"3715_CR3","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, Fan ZP, Wu DP, Huang XJ (2015) Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 125(25):3956\u20133962. \n                    https:\/\/doi.org\/10.1182\/blood-2015-02-627786","journal-title":"Blood"},{"issue":"5","key":"3715_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbmt.2009.02.001","volume":"15","author":"YJ Chang","year":"2009","unstructured":"Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Yu W, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ (2009) Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Biol Blood Marrow Transplant 15(5):632\u2013638. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2009.02.001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"3715_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3324\/haematol.2011.044966","volume":"96","author":"H Nakamae","year":"2011","unstructured":"Nakamae H, Storer B, Sandmaier BM, Maloney DG, Davis C, Corey L, Storb R, Boeckh M (2011) Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient\/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96(12):1838\u20131845. \n                    https:\/\/doi.org\/10.3324\/haematol.2011.044966","journal-title":"Haematologica"},{"issue":"7","key":"3715_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/sj.bmt.1704428","volume":"33","author":"KH Lee","year":"2004","unstructured":"Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Kim WK, Lee JS (2004) Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes. Bone Marrow Transplant 33(7):729\u2013734. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704428","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3715_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02468.x","volume":"112","author":"A Dominietto","year":"2001","unstructured":"Dominietto A, Raiola AM, van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Frassoni F, Casarino L, Verdiani S, Bacigalupo A (2001) Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 112(1):219\u2013227","journal-title":"Br J Haematol"},{"issue":"1","key":"3715_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1083-8791(00)70049-8","volume":"6","author":"RA Nash","year":"2000","unstructured":"Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R (2000) A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 6(1):25\u201334","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3715_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","volume":"7","author":"B Bruno","year":"2001","unstructured":"Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, Nash RA (2001) Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7(3):154\u2013162. \n                    https:\/\/doi.org\/10.1053\/bbmt.2001.v7.pm11302549","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"3715_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","volume":"22","author":"Y Akahoshi","year":"2016","unstructured":"Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda Y (2016) Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 22(9):1678\u20131683. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"3715_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbmt.2013.07.014","volume":"19","author":"Y Kong","year":"2013","unstructured":"Kong Y, Chang YJ, Wang YZ, Chen YH, Han W, Wang Y, Sun YQ, Yan CH, Wang FR, Liu YR, Xu LP, Liu DH, Huang XJ (2013) Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19(10):1465\u20131473. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2013.07.014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"3715_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2141.1994.tb04922.x","volume":"87","author":"S Bilgrami","year":"1994","unstructured":"Bilgrami S, Almeida GD, Quinn JJ, Tuck D, Bergstrom S, Dainiak N, Poliquin C, Ascensao JL (1994) Pancytopenia in allogeneic marrow transplant recipients: role of cytomegalovirus. Br J Haematol 87(2):357\u2013362","journal-title":"Br J Haematol"},{"issue":"6","key":"3715_CR13","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1128\/JCM.00702-14","volume":"52","author":"A Capobianchi","year":"2014","unstructured":"Capobianchi A, Iori AP, Micozzi A, Torelli GF, Testi AM, Girmenia C, Santilli S, Barberi W, Antonelli G, Foa R, Gentile G (2014) Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes. J Clin Microbiol 52(6):2183\u20132185. \n                    https:\/\/doi.org\/10.1128\/JCM.00702-14","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3715_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/stem.1691","volume":"32","author":"M von Bonin","year":"2014","unstructured":"von Bonin M, Bornhauser M (2014) Concise review: the bone marrow niche as a target of graft versus host disease. Stem Cells 32(6):1420\u20131428. \n                    https:\/\/doi.org\/10.1002\/stem.1691","journal-title":"Stem Cells"},{"key":"3715_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fimmu.2016.00118","volume":"7","author":"M Szyska","year":"2016","unstructured":"Szyska M, Na IK (2016) Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation. Front Immunol 7:118. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00118","journal-title":"Front Immunol"},{"issue":"9","key":"3715_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.bbmt.2014.05.009","volume":"20","author":"Y Lin","year":"2014","unstructured":"Lin Y, Hu X, Cheng H, Pang Y, Wang L, Zou L, Xu S, Zhuang X, Jiang C, Yuan W, Cheng T, Wang J (2014) Graft-versus-host disease causes broad suppression of hematopoietic primitive cells and blocks megakaryocyte differentiation in a murine model. Biol Blood Marrow Transplant 20(9):1290\u20131300. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2014.05.009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"3715_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.bmt.1705072","volume":"36","author":"H Bittencourt","year":"2005","unstructured":"Bittencourt H, Rocha V, Filion A, Ionescu I, Herr AL, Garnier F, Ades L, Esperou H, Devergie A, Ribaud P, Socie G, Gluckman E (2005) Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders. Bone Marrow Transplant 36(5):431\u2013435. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1705072","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3715_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000487229","volume":"11","author":"S Master","year":"2018","unstructured":"Master S, Dwary A, Mansour R, Mills GM, Koshy N (2018) Use of eltrombopag in improving poor graft function after allogeneic hematopoietic stem cell transplantation. Case Reports in Oncol 11(1):191\u2013195. \n                    https:\/\/doi.org\/10.1159\/000487229","journal-title":"Case Reports in Oncol"},{"issue":"3","key":"3715_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/tme.12300","volume":"26","author":"J Dyba","year":"2016","unstructured":"Dyba J, Tinmouth A, Bredeson C, Matthews J, Allan DS (2016) Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature. Transfus Med 26(3):202\u2013207. \n                    https:\/\/doi.org\/10.1111\/tme.12300","journal-title":"Transfus Med"},{"issue":"9","key":"3715_CR20","first-page":"730","volume":"52","author":"YQ Sun","year":"2013","unstructured":"Sun YQ, Liu DH, Xu LP, Zhang XH, Liu KY, Huang XJ (2013) The efficacy and safety of recombinant human granulocyte colony stimulating factor primed donor peripheral cell harvest in treatment of poor graft function after allogeneic stem cell transplantation. Zhonghua Nei Ke Za Zhi 52(9):730\u2013733","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"3715_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/bjh.15012","volume":"180","author":"C Mainardi","year":"2018","unstructured":"Mainardi C, Ebinger M, Enkel S, Feuchtinger T, Teltschik HM, Eyrich M, Schumm M, Rabsteyn A, Schlegel P, Seitz C, Schwarze CP, Muller I, Greil J, Bader P, Schlegel PG, Martin D, Holzer U, Doring M, Handgretinger R, Lang P (2018) CD34(+) selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation. Br J Haematol 180(1):90\u201399. \n                    https:\/\/doi.org\/10.1111\/bjh.15012","journal-title":"Br J Haematol"},{"issue":"7","key":"3715_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bbmt.2017.03.019","volume":"23","author":"A Ghobadi","year":"2017","unstructured":"Ghobadi A, Fiala MA, Ramsingh G, Gao F, Abboud CN, Stockerl-Goldstein K, Uy GL, Grossman BJ, Westervelt P, DiPersio JF (2017) Fresh or cryopreserved CD34(+)-selected mobilized peripheral blood stem and progenitor cells for the treatment of poor graft function after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 23(7):1072\u20131077. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"3715_CR23","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3727\/096368912X661319","volume":"23","author":"X Liu","year":"2014","unstructured":"Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F, Fan Z, Zhou H, Wu X, Yu G, Zhang X, Li Y, Xiao Y, Song C, Xiang AP, Liu Q (2014) Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study. Cell Transplant 23(9):1087\u20131098. \n                    https:\/\/doi.org\/10.3727\/096368912X661319","journal-title":"Cell Transplant"},{"issue":"1","key":"3715_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-017-1159-y","volume":"15","author":"Y Kong","year":"2017","unstructured":"Kong Y, Wang YT, Cao XN, Song Y, Chen YH, Sun YQ, Wang Y, Zhang XH, Xu LP, Huang XJ (2017) Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation. J Transl Med 15(1):57. \n                    https:\/\/doi.org\/10.1186\/s12967-017-1159-y","journal-title":"J Transl Med"},{"issue":"25","key":"3715_CR25","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2016-03-702803","volume":"128","author":"MM Shi","year":"2016","unstructured":"Shi MM, Kong Y, Song Y, Sun YQ, Wang Y, Zhang XH, Xu LP, Liu KY, Huang XJ (2016) Atorvastatin enhances endothelial cell function in posttransplant poor graft function. Blood 128(25):2988\u20132999. \n                    https:\/\/doi.org\/10.1182\/blood-2016-03-702803","journal-title":"Blood"},{"issue":"8","key":"3715_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bbmt.2016.04.016","volume":"22","author":"YT Wang","year":"2016","unstructured":"Wang YT, Kong Y, Song Y, Han W, Zhang YY, Zhang XH, Chang YJ, Jiang ZF, Huang XJ (2016) Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22(8):1376\u20131382. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.04.016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"3715_CR27","doi-asserted-by":"publisher","first-page":"30892","DOI":"10.18632\/oncotarget.8810","volume":"7","author":"Y Kong","year":"2016","unstructured":"Kong Y, Song Y, Hu Y, Shi MM, Wang YT, Wang Y, Zhang XH, Xu LP, Liu KY, Deng HK, Huang XJ (2016) Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants. Oncotarget 7(21):30892\u201330906. \n                    https:\/\/doi.org\/10.18632\/oncotarget.8810","journal-title":"Oncotarget"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03715-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:11:33Z","timestamp":1590621093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03715-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3715"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03715-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Peking University People\u2019s Hospital approved this study. All procedures performed in these studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committees and with the 1964 Helsinki declaration and its later amendments, or with some comparable ethical standards. All patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}